BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Ding Y, Deng Y, Zheng Y, Wang S. Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer. J Immunother Cancer 2020;8:e000609. [PMID: 33051339 DOI: 10.1136/jitc-2020-000609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhou S, Fan C, Zeng Z, Young KH, Li Y. Clinical and Immunological Effects of p53-Targeting Vaccines. Front Cell Dev Biol 2021;9:762796. [PMID: 34805170 DOI: 10.3389/fcell.2021.762796] [Reference Citation Analysis]
2 Xiao T, Zhang P, Feng T, Lu K, Wang X, Zhou S, Qiang Y. Butyrate functions in concert with myeloid-derived suppressor cells recruited by CCR9 to alleviate DSS-induced murine colitis. Int Immunopharmacol 2021;99:108034. [PMID: 34426112 DOI: 10.1016/j.intimp.2021.108034] [Reference Citation Analysis]
3 Andreuzzi E, Fejza A, Polano M, Poletto E, Camicia L, Carobolante G, Tarticchio G, Todaro F, Di Carlo E, Scarpa M, Scarpa M, Paulitti A, Capuano A, Canzonieri V, Maiero S, Fornasarig M, Cannizzaro R, Doliana R, Colombatti A, Spessotto P, Mongiat M. Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway. J Exp Clin Cancer Res 2022;41:60. [PMID: 35148799 DOI: 10.1186/s13046-022-02271-y] [Reference Citation Analysis]
4 Chen Z, Huang Y, Hu Z, Zhao M, Bian Y, Chen Z, Zheng Y, Bi G, Pang Y, Zhan C, Lin Z, Guo W, Wang Q, Tan L. Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. Oncogenesis 2021;10:71. [PMID: 34697289 DOI: 10.1038/s41389-021-00359-2] [Reference Citation Analysis]
5 Andrea AE, Chiron A, Mallah S, Bessoles S, Sarrabayrouse G, Hacein-Bey-Abina S. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Front Immunol 2022;13:830292. [PMID: 35211124 DOI: 10.3389/fimmu.2022.830292] [Reference Citation Analysis]
6 Ashkenazi-Preiser H, Mikula I Jr, Baniyash M. The diverse roles of myeloid derived suppressor cells in mucosal immunity. Cell Immunol 2021;365:104361. [PMID: 33984533 DOI: 10.1016/j.cellimm.2021.104361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Choi YY, Seong KM, Lee HJ, Lee SS, Kim A. Expansion of monocytic myeloid-derived suppressor cells ameliorated intestinal inflammatory response by radiation through SOCS3 expression. Cell Death Dis 2021;12:826. [PMID: 34480017 DOI: 10.1038/s41419-021-04103-x] [Reference Citation Analysis]
8 Chen Z, Zhang X, Xing Z, Lv S, Huang L, Liu J, Ye S, Li X, Chen M, Zuo S, Tao Y, He Y. OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment. Oncogene 2022. [PMID: 35487976 DOI: 10.1038/s41388-022-02324-8] [Reference Citation Analysis]
9 Shao X, Sun S, Zhou Y, Wang H, Yu Y, Hu T, Yao Y, Zhou C. Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis. Cancer Lett 2021;523:170-81. [PMID: 34627951 DOI: 10.1016/j.canlet.2021.10.002] [Reference Citation Analysis]